Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bioxcel Therapeutics Inc
(NQ:
BTAI
)
17.70
-0.18 (-1.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
499,411
Open
17.75
Bid (Size)
17.10 (10)
Ask (Size)
18.12 (2)
Prev. Close
17.88
Today's Range
17.52 - 18.13
52wk Range
8.795 - 34.12
Shares Outstanding
29,009,536
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Meta Platforms To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Tuesday
March 21, 2023
Morgan Stanley boosted the price target for HubSpot, Inc. (NYSE: HUBS) from $447 to $466. Morgan Stanley analyst Keith Weiss maintained an Overweight rating. HubSpot shares fell 1.9% to close at...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
March 10, 2023
Via
Benzinga
Performance
YTD
-17.52%
-17.52%
1 Month
-42.44%
-42.44%
3 Month
-18.62%
-18.62%
6 Month
+57.33%
+57.33%
1 Year
-14.04%
-14.04%
More News
Read More
6 Analysts Have This to Say About BioXcel Therapeutics
March 10, 2023
Via
Benzinga
Earnings Preview: BioXcel Therapeutics
March 08, 2023
Via
Benzinga
Expert Ratings for BioXcel Therapeutics
February 08, 2023
Via
Benzinga
Why BioXCel Therapeutics Stock Jumped This Week
December 15, 2022
Via
The Motley Fool
Analyst Ratings for BioXcel Therapeutics
December 01, 2022
Via
Benzinga
Is This Soaring Growth Stock a Buy?
November 20, 2022
Via
The Motley Fool
BioXcel Therapeutics Unveils Complete Data From BXCL701/Keytruda Combo Study In Prostate Cancer Subtype
February 14, 2023
Via
Benzinga
Analyst Reiterates This Alzheimer's Candidate As Top Idea For 2023
February 08, 2023
Via
Benzinga
ChatGPT Is Just The 'Tip Of The Iceberg' In Content-Creating Artificial Intelligence; Get Ready For 'A Lot Of Disruption' (Not Just At Google)
February 03, 2023
Via
Investor's Business Daily
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
January 06, 2023
Via
Investor's Business Daily
Recap: BioXcel Therapeutics Q2 Earnings
August 09, 2022
Via
Benzinga
BioXcel Therapeutics: Q1 Earnings Insights
May 09, 2022
Via
Benzinga
2 Beaten-Down Stocks to Watch Closely Next Year
December 06, 2022
Via
The Motley Fool
Why BioXcel Therapeutics Stock Triumphed This Week
December 02, 2022
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via
Benzinga
Cramer On This Stock Down 65% Year-To-Date: 'I Do Believe It's Bottoming, But I Don't Know What Gets It Higher'
November 18, 2022
Via
Benzinga
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
July 14, 2022
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
July 07, 2022
Via
Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
June 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 25, 2022
Via
Benzinga
Preview: BioXcel Therapeutics's Earnings
May 06, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.